MARKET

LRMR

LRMR

Larimar Therapeutics Inc
NASDAQ
2.000
-0.150
-6.98%
After Hours: 2.100 +0.1 +5.00% 16:29 04/01 EDT
OPEN
2.120
PREV CLOSE
2.150
HIGH
2.120
LOW
1.960
VOLUME
927.90K
TURNOVER
--
52 WEEK HIGH
11.20
52 WEEK LOW
1.960
MARKET CAP
128.06M
P/E (TTM)
-1.5199
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LRMR last week (0324-0328)?
Weekly Report · 1d ago
Promising Outlook for Larimar Therapeutics: Buy Rating on Nomlabofusp’s Potential in Treating Friedreich’s Ataxia
TipRanks · 5d ago
Promising Developments and Financial Strength Support Buy Rating for Larimar Therapeutics
TipRanks · 5d ago
Larimar Therapeutics should be bought on weakness, says Citi
TipRanks · 03/25 19:08
Larimar Therapeutics price target raised to $16 from $15 at H.C. Wainwright
TipRanks · 03/25 19:06
Larimar Therapeutics price target lowered to $10 from $13 at Baird
TipRanks · 03/25 18:59
Larimar Therapeutics Price Target Maintained With a $26.00/Share by Guggenheim
Dow Jones · 03/25 14:21
Guggenheim Reiterates Buy on Larimar Therapeutics, Maintains $26 Price Target
Benzinga · 03/25 14:10
More
About LRMR
More
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide (CPP) technology platform. The Company’s lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver tissue frataxin (FXN), an essential protein, to the mitochondria of patients with Friedreich's ataxia (FA). FA is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. Its CPP platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential to enable the treatment of other rare and orphan diseases. It intends to use its proprietary platform to target additional orphan indications characterized by deficiencies in or alterations of intracellular content or activity.
Recently
Symbol
Price
%Change

Webull offers Larimar Therapeutics Inc stock information, including NASDAQ: LRMR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LRMR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LRMR stock methods without spending real money on the virtual paper trading platform.